期刊文献+

探寻18F-FDG PET/CT显像在浆细胞骨髓瘤诊断中的应用价值 被引量:1

The application value of 18F-FDG PET/CT imaging in the diagnosis of plasma cell myeloma
下载PDF
导出
摘要 目的探讨浆细胞骨髓瘤的18F-FDGPET/CT影像表现及鉴别诊断。方法回顾性分析2009-2014年间我院行PET/CT检查后,并经临床确诊的36例浆细胞骨髓瘤。结果PET显像病灶SUV最大值2.04~10.41不等,平均值为4.88,其中SUV最大值≤5.0的20例、SUV最大值5~10的15例、SUV最大值≥10的1例,病灶SUV最大值≤5.0的发生率与其他区间差异具有统计学意义(P〈0.05)。所有患者均未见髓外组织浸润。结论18F-FDGPET/CT对于诊断浆细胞骨髓瘤是一项非常有用的技术。 Objective To explore 18F-FDG PET/CT imaging manifestations and differential diag- nosis of plasma cell myeloma. Methods The clinical data of 36 patients (male 20 cases, female 16 cases) with plasma cell myeloma, who received 18F-FDG PET/CT examination from 2009 to 2014, were retrospectively analyzed. Results PET imaging focal SUV maximum range of 2.04~ 10.41, with a mean of 4.88. The SUV maximum 5.0 or less a maximum of 20 cases, SUV 5~10 of 15 cases, SUV maximum of more than 10 in 1 case, lesions SUV maximum incidence and other range of 5.0 or less had statistically significant difference (P〈0.05). All patients were not seen pith tissue infiltration. Conclusion 18F-FDG PET/CT is a very useful technique in the diagnosis of plasma ceil myeloma.
机构地区 解放军第
出处 《颈腰痛杂志》 2015年第5期374-376,共3页 The Journal of Cervicodynia and Lumbodynia
关键词 体层摄影术 发射型计算机 18氟-脱氧葡萄糖 浆细胞骨髓瘤 body section radiography emission-computed 18 fluorine-deoxidization glucose plasma cell myeloma
  • 相关文献

参考文献8

  • 1Collins C D. Multiple myeloma[J]. Cancer Imaging,2004,4:47-53.
  • 2Barlogie B,Shaughnessy J,Tricot G,et al. Treatment of nmhiple myeloma[J]. Blood, 2094,103 : 20-32.
  • 3Zaidi H,Montandon ML,Alavi A. The clinical role of thsion imaging using PET/CT,CT,and MR imaging[J]. Magn Reson Imaging Clin N (Am),2010,18:133-149.
  • 4Dimopoulos M,Terpos E,Comenzo RL,et al. lnternaotional myelo- ma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and mon- itoring of muhiple Myeloma[J]. Leukemia.2009,23 : 1545-1556.
  • 5Walker RC,Brown TL,Jones-Jackson l,B,et al. inmging of muhi-pie myeloma and related plasma cell dyscrasias[J]. J Nucl Med, 2012,53 : 1091-1101,.
  • 6Durie BG,Salmon SE. A clinical staging system for muhiple myeloma.Con'elation of measured myeloma cell mass with pre- senting clinical t~atures, response to treatment,and survival[J]. Cancer, 1975,36 : 842-854.
  • 7Bredella MA,Steinbaeh L,Caputo G,et al. Value of FDG PET/ CT in the assessment of patients with muhiple myeloma[J]. AJR Am J Roentgenol, 2005,184: 1 199-1204.
  • 8Wiesenthal AA,Nguyen BI). F-18 FDG PET/CT staging of mul- tiple myeloma with diffuse osseous and extramedullary lesions[J]. Clin Nucl Med,2007,32:797-801.

同被引文献14

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部